Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 1
Submit an article Journal homepage
217
Views
20
CrossRef citations to date
0
Altmetric
Drug Evaluation

BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma

Seung-Tae Lee Postdoctoral Fellow, The University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. [email protected]
,
Yun-Fang Jiang Research Scientist, The University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. [email protected]
,
Keon-Uk Park Postdoctoral Fellow, The University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. [email protected]
,
Alison F Woo Grant Program Manager, The University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. [email protected]
&
Sattva S Neelapu Assistant Professor, The University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. [email protected]
Pages 113-122 | Published online: 06 Dec 2006

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Chizuru Ogi & Atsushi Aruga. (2013) Immunological monitoring of anticancer vaccines in clinical trials. OncoImmunology 2:8.
Read now
Chizuru Ogi & Atsushi Aruga. (2013) Clinical evaluation of therapeutic cancer vaccines. Human Vaccines & Immunotherapeutics 9:5, pages 1049-1057.
Read now
Hui Liu, Peng Cai, Hong-Xing Liu, Jian-Ling Wang, Qian Liu & Ping Zhu. (2011) Vaccination with immunoglobulin frame region-derived nonapeptide elicits cellular immune response against lymphoma in human leukocyte antigen-A2.1 transgenic mice. Leukemia & Lymphoma 52:9, pages 1795-1802.
Read now
Philippe Fournier & Volker Schirrmacher. (2009) Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. Expert Review of Vaccines 8:1, pages 51-66.
Read now
Xavier Thomas. (2008) New emerging applications of molgramostim in acute myeloid leukaemia. Expert Opinion on Drug Metabolism & Toxicology 4:6, pages 795-806.
Read now

Articles from other publishers (15)

Jay A. Berzofsky, Purevdorj B. Olkhanud & Hoyoung M. Maeng. 2023. Plotkin's Vaccines. Plotkin's Vaccines 191 210.e9 .
Hoyoung M. Maeng & Jay A. Berzofsky. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine 307 328 .
Hoyoung M. Maeng & Jay A. Berzofsky. (2019) Strategies for developing and optimizing cancer vaccines. F1000Research 8, pages 654.
Crossref
Yiqun HuangYong ZouLuhui LinRuiji Zheng. (2017) Ginsenoside Rg1 Activates Dendritic Cells and Acts as a Vaccine Adjuvant Inducing Protective Cellular Responses Against Lymphomas. DNA and Cell Biology 36:12, pages 1168-1177.
Crossref
Elias J Sayour, Luis Sanchez-Perez, Catherine Flores & Duane A Mitchell. (2015) Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Chizuru Ogi & Atsushi Aruga. (2015) Approaches to improve development methods for therapeutic cancer vaccines. Immunology Letters 164:2, pages 100-108.
Crossref
Elias J. Sayour, Pat McLendon, Roger McLendon, Gabriel De Leon, Renee Reynolds, Jesse Kresak, John H. Sampson & Duane A. Mitchell. (2015) Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunology, Immunotherapy 64:4, pages 419-427.
Crossref
Natalia Savelyeva, Michael Shipton, Amy Suchacki, Gavin Babbage & Freda K. Stevenson. (2011) High-affinity memory B cells induced by conjugate vaccines against weak tumor antigens are vulnerable to nonconjugated antigen. Blood 118:3, pages 650-659.
Crossref
Stephen J. SchusterSattva S. NeelapuBarry L. GauseJohn E. JanikFranco M. MuggiaJon P. GockermanJane N. WinterChristopher R. FlowersDaniel A. NikcevichEduardo M. SotomayorDean S. McGaugheyElaine S. JaffeElise A. ChongCraig W. ReynoldsDonald A. BerryCarlos F. SantosMihaela A. PopaAmy M. McCordLarry W. Kwak. (2011) Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma. Journal of Clinical Oncology 29:20, pages 2787-2794.
Crossref
A. Kantele, M. P. Häkkinen, J. Zivny, C. O. Elson, J. Mestecky & J. M. Kantele. (2011) Humoral Immune Response to Keyhole Limpet Haemocyanin, the Protein Carrier in Cancer Vaccines. Clinical and Developmental Immunology 2011, pages 1-6.
Crossref
Kedar G. Patel, Patrick P. Ng, Shoshana Levy, Ronald Levy & James R. Swartz. (2011) Escherichia coli-based production of a tumor idiotype antibody fragment – tetanus toxin fragment C fusion protein vaccine for B cell lymphoma. Protein Expression and Purification 75:1, pages 15-20.
Crossref
Barbara Zehnbauer & Mona Nasser. 2011. Hematopathology. Hematopathology 293 323 .
Hyun Jun Park & Sattva S. Neelapu. (2008) Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials. British Journal of Haematology 142:2, pages 179-191.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:3, pages 148-155.
Crossref
Sattva S. Neelapu & Larry W. Kwak. (2007) Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies. Hematology 2007:1, pages 243-249.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.